Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

BioMed Research International
Volume 2016, Article ID 5631935, 7 pages
http://dx.doi.org/10.1155/2016/5631935
Research Article

Expression of HIF-2α and VEGF in Cervical Squamous Cell Carcinoma and Its Clinical Significance

1Jiaxing Maternity and Child Health Care Hospital, Jianxin 314050, China
2Department of Physiology, Basic Medical College, Nanchang University, Nanchang 330006, China
3The First Clinical Medical College, Nanchang University, Nanchang 330006, China
4The Second Clinical Medical College, Nanchang University, Nanchang 330006, China

Received 19 February 2016; Accepted 26 May 2016

Academic Editor: Mi-Yeon Jung

Copyright © 2016 Lixia Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Yang, H. Zhu, Y. Ge et al., “Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1α,” Tumor Biology, vol. 35, no. 10, pp. 10443–10448, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Tian, S. L. McKnight, and D. W. Russell, “Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells,” Genes & Development, vol. 11, no. 1, pp. 72–82, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Kaio, S. Tanaka, Y. Kitadai et al., “Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma,” Oncology, vol. 64, no. 1, pp. 61–73, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. I.-J. Lee, K.-R. Park, K.-K. Lee et al., “Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix,” International Journal of Radiation Oncology, Biology, Physics, vol. 54, no. 3, pp. 768–779, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-J. Park, M.-S. Kim, K. Cho, J.-H. Yun, Y.-J. Choi, and C.-H. Cho, “Disulfiram deregulates HIF-α subunits and blunts tumor adaptation to hypoxia in hepatoma cells,” Acta Pharmacologica Sinica, vol. 34, no. 9, pp. 1208–1216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Lando, D. J. Peet, D. A. Whelan, J. J. Gorman, and M. L. Whitelaw, “Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch,” Science, vol. 295, no. 5556, pp. 858–861, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. van Hagen, R. M. Overmeer, S. S. Abolvardi, and A. C. O. Vertegaal, “RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated hypoxia-inducible factor-2α,” Nucleic Acids Research, vol. 38, no. 6, pp. 1922–1931, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G.-H. Fong and K. Takeda, “Role and regulation of prolyl hydroxylase domain proteins,” Cell Death & Differentiation, vol. 15, no. 4, pp. 635–641, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Majmundar, W. J. Wong, and M. C. Simon, “Hypoxia-inducible factors and the response to hypoxic stress,” Molecular Cell, vol. 40, no. 2, pp. 294–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. X.-H. Wu, C. Qian, and K. Yuan, “Correlations of hypoxia-inducible factor-1α/hypoxia-inducible factor -2α expression with angiogenesis factors expression and prognosis in non-small cell lung cancer,” Chinese Medical Journal, vol. 124, no. 1, pp. 11–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Mamlouk and B. Wielockx, “Hypoxia-inducible factors as key regulators of tumor inflammation,” International Journal of Cancer, vol. 132, no. 12, pp. 2721–2729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. K. L. Talks, H. Turley, K. C. Gatter et al., “The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages,” The American Journal of Pathology, vol. 157, no. 2, pp. 411–421, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Patel and M. C. Simon, “Biology of hypoxia-inducible factor-2α in development and disease,” Cell Death and Differentiation, vol. 15, no. 4, pp. 628–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. R. D. Catalano, M. R. Wilson, S. C. Boddy, A. T. M. McKinlay, K. J. Sales, and H. N. Jabbour, “Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth,” PLoS ONE, vol. 6, no. 5, Article ID e19209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. B. L. Petrella and C. E. Brinckerhoff, “PTEN suppression of YY1 induces HIF-2 activity in von hippel lindau null renal cell carcinoma,” Cancer Biology and Therapy, vol. 8, no. 14, pp. 1389–1401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Karali, S. Bellou, D. Stellas, A. Klinakis, C. Murphy, and T. Fotsis, “VEGF signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress,” Molecular Cell, vol. 54, no. 4, pp. 559–572, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Nakayama, A. Nakayama, M. van Lessen et al., “Spatial regulation of VEGF receptor endocytosis in angiogenesis,” Nature Cell Biology, vol. 15, no. 3, pp. 249–260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Zhang, B. Lee, M. Korecka et al., “Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I (+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia,” Leukemia Research, vol. 23, no. 4, pp. 373–384, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Scortegagna, M. A. Morris, Y. Oktay, M. Bennett, and J. A. Garcia, “The HIF family member EPAS1/HIF-2α is required for normal hematopoiesis in mice,” Blood, vol. 102, no. 5, pp. 1634–1640, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. K. Kim, T.-J. Kim, C.-O. Sung et al., “Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer,” Journal of Gynecologic Oncology, vol. 22, no. 1, pp. 44–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Kawanaka, A. Kubo, H. Ikushima, T. Sano, Y. Takegawa, and H. Nishitani, “Prognostic significance of HIF-2α expression on tumor infiltrating macrophages in patients with uterine cervical cancer undergoing radiotherapy,” Journal of Medical Investigation, vol. 55, no. 1-2, pp. 78–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. P. Munksgaard, M. E. Johansson, N. Monsef et al., “HIF-2α expression is suppressed in SCLC cells, which survive in moderate and severe hypoxia when HIF-1α is repressed,” American Journal of Pathology, vol. 180, no. 2, pp. 494–504, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Wei, X. Liu, and C. Hu, “Correlation between expression of HIF-2α and OCT-4 and prognosis of NSCLC,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 36, no. 9, pp. 854–858, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Balaiya, V. Khetpal, and K. V. Chalam, “Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2α,” Molecular Vision, vol. 18, pp. 114–120, 2012. View at Google Scholar · View at Scopus
  25. B. Keith, R. S. Johnson, and M. C. Simon, “HIF1 α and HIF2 α: sibling rivalry in hypoxic tumour growth and progression,” Nature Reviews Cancer, vol. 12, no. 1, pp. 9–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Wang and A. Schneider, “HIF-2α-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia,” Carcinogenesis, vol. 31, no. 7, pp. 1202–1210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Uchida, F. Rossignol, M. A. Matthay et al., “Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1α and HIF-2α expression in lung epithelial cells: Implication of natural antisense HIF-1α,” Journal of Biological Chemistry, vol. 279, no. 15, pp. 14871–14878, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Y. Koh and G. Powis, “Passing the baton: the HIF switch,” Trends in Biochemical Sciences, vol. 37, no. 9, pp. 364–372, 2012. View at Publisher · View at Google Scholar · View at Scopus